January 19, 2017 7:06 AM ET

Life Sciences Tools and Services

Company Overview of Myriad RBM, Inc.

Company Overview

Myriad RBM, Inc., a multiplexed immunoassay testing laboratory, provides multi-analyte profile (MAP) technology platform based protein biomarker products and services for research, drug, and diagnostic development projects. Its products and services include HumanMAP services that assist investigators in the discovery, validation, and clinical use of biomarker patterns in biological samples, such as serum or plasma; and RodentMAP services that provide quantitative measurement of various biomarkers to enable new pattern discovery, as well as sensitive safety and efficacy assessments. The company’s products and services also comprise single molecule array technology based Ultrasensitive Immunoa...

3300 Duval Road

Austin, TX 78759

United States

Founded in 2002

141 Employees





Key Executives for Myriad RBM, Inc.

Age: 61
Chief Scientific Officer and Senior Vice President
Age: 67
Chief Medical Officer and Senior Vice President
Age: 63
Vice President of IS & Technology
Managing Director of Communications
Compensation as of Fiscal Year 2016.

Myriad RBM, Inc. Key Developments

Myriad RBM DiscoveryMAP(R) Technology Identifies Novel Biomarkers That May Predict Increased Risk of Cardiovascular Events in Patients with Diabetes

Myriad RBM announced that its DiscoveryMAP® platform successfully identified combinations of 15 protein biomarkers associated with cardiovascular (CV) events or death in people with pre-diabetes or early type 2 diabetes, according to a study published by the journal Circulation. DiscoveryMAP is a comprehensive, quantitative, immunoassay service product that measures more than 300 human proteins. It is the culmination of 15 years of assay development for cytokines, chemokines, metabolic markers, hormones, growth factors, tissue remodeling proteins, angiogenesis markers, acute phase reactants, cancer markers, kidney damage markers, CNS biomarkers and other important circulating proteins.

CDC Plans Sole Source with Rules-Based Medicine for Proteome Evaluation

The U.S. Health and Human Services Department's Centers for Disease Control and Prevention, Atlanta, said it intends to enter into a sole source contract (2015-63697SG) with Rules-Based Medicine Inc., Austin, Texas, for the evaluation of proteomes.

Myriad RBM Launches New Immunoassay Services Based on the Ultrasensitive Simoa(TM) Platform

Myriad RBM announced the launch of immunoassay services based on the ultrasensitive Simoa™ (single molecule array) platform developed by Quanterix. The Simoa platform enables the accurate measurement of protein biomarkers that were previously difficult or even impossible to detect in blood samples. Initially, Myriad RBM will offer Simoa assay services for the study of inflammatory and autoimmune diseases. The company has manufactured and validated Simoa-based quantitative immunoassays for interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) that are available from its CLIA-certified laboratory in Austin, Texas. Each assay includes carefully designed calibrators and controls to provide multiple measurements of quality, precision and accuracy. Myriad RBM plans to add more Simoa-based immunoassays throughout the year.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Myriad RBM, Inc., please visit myriadrbm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.